InfuSystem Holdings, Inc

NYSE:INFU

Surgical & Medical Instruments & Apparatus·ROCHESTER HILLS, MI

CEO

Lachance Carrie

CFO

Steele Barry G

Summary Financials

Revenue

$134.9M

+7.2% YoY

FY 2025

Adj. EBITDA

$19.4M

14.4% margin

FY 2025

Net Income

$2.3M

1.7% margin

FY 2025

EPS (Diluted)

$0.11

FY 2025

Stock Price

$9.45

-2.4%

2026-03-09

52W Range

$4.61 – $11.04

P/E Ratio

85.9x

Market Cap

$191.0M

Cash

$527,000

FY 2025

Total Debt

$23.9M

FY 2025

Net Debt

$23.3M

FY 2025

Enterprise Value

$214.4M

Debt / EBITDA

1.2x

FY 2025

EV / EBITDA

11.1x

Employees

—

Revenue

$134.9M

+7.2% YoY

FY 2025

Adj. EBITDA

$19.4M

14.4% margin

FY 2025

Net Income

$2.3M

1.7% margin

FY 2025

EPS (Diluted)

$0.11

FY 2025

Stock Price

$9.45

-2.4%

2026-03-09

52W Range

$4.61 – $11.04

P/E Ratio

85.9x

Market Cap

$191.0M

Cash

$527,000

FY 2025

Total Debt

$23.9M

FY 2025

Net Debt

$23.3M

FY 2025

Enterprise Value

$214.4M

Debt / EBITDA

1.2x

FY 2025

EV / EBITDA

11.1x

Employees

—